We are live on
!
Find out more
HCM
Highbridge Capital Management Portfolio holdings
AUM
$3.09B
1-Year Est. Return
31.21%
This Fund
S&P 500
This Quarter
Est. Return
+2.01%
1 Year Est. Return
+31.21%
3 Year Est. Return
+54.52%
5 Year Est. Return
+78.37%
10 Year Est. Return
+191.37%
AUM
$6.7B
AUM Growth
-$185M
(-2.7%)
Cap. Flow
-$1.21B
Cap. Flow
% of AUM
-18.12%
Top 10 Holdings %
Top 10 Hldgs %
19.64%
Holding
1,898
New
496
Increased
278
Reduced
343
Closed
709
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$91.8M |
| 2 |
AABA
Altaba Inc
AABA
|
+$52.5M |
| 3 |
ALR.PRB
Alere Inc
ALR.PRB
|
+$32M |
| 4 |
Colgate-Palmolive
CL
|
+$31.2M |
| 5 |
TPGE.U
TPG Pace Energy Holdings Corp.
TPGE.U
|
+$30.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SYT
Syngenta Ag
SYT
|
+$35.4M |
| 2 |
Hewlett Packard
HPE
|
+$33.6M |
| 3 |
PVTB
PrivateBancorp Inc
PVTB
|
+$28.5M |
| 4 |
Tyson Foods
TSN
|
+$27M |
| 5 |
Baxter International
BAX
|
+$23.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.74% |
| 2 | Consumer Discretionary | 7.4% |
| 3 | Healthcare | 5.11% |
| 4 | Consumer Staples | 4.38% |
| 5 | Communication Services | 3.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Seres Therapeutics
MCRB
$48.4M
| $252K | ﹤0.01% |
1,113
-429
| -28% | -$88.1K |
|
|
EGOV
977
DELISTED
NIC Inc
EGOV
| $252K | ﹤0.01% |
13,261
-11,009
| -45% | -$225K |
|
|
GWR
978
PUT
DELISTED
Genesee & Wyoming Inc.
GWR
| $252K | ﹤0.01% |
+3,700
| New | +$244K |
|
|
VSI
979
DELISTED
Vitamin Shoppe Inc.
VSI
| $251K | ﹤0.01% |
+21,566
| New | +$318K |
|
980
Medpace
MEDP
$16.5B
| $250K | ﹤0.01% |
+8,623
| New | +$242K |
|
981
Lam Research
LRCX
$390B
| $249K | ﹤0.01% |
17,600
-18,120
| -51% | -$266K |
|
|
INFO
982
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $249K | ﹤0.01% |
5,647
-55,190
| -91% | -$2.46M |
|
|
WAAS
983
DELISTED
AquaVenture Holdings Limited
WAAS
| $249K | ﹤0.01% |
+16,321
| New | +$278K |
|
984
PUT
Zoetis
ZTS
$30B
| $248K | ﹤0.01% |
+4,000
| New | +$236K |
|
|
FLG
985
PUT
Flagstar Bank National Association
FLG
$5.82B
| $248K | ﹤0.01% |
6,267
-1,866
| -23% | -$74.2K |
|
|
RSPP
986
DELISTED
RSP Permian, Inc.
RSPP
| $248K | ﹤0.01% |
+7,692
| New | +$286K |
|
987
PUT
Eli Lilly
LLY
$1.06T
| $247K | ﹤0.01% |
3,000
-2,600
| -46% | -$212K |
|
|
WP
988
PUT
DELISTED
Worldpay, Inc.
WP
| $247K | ﹤0.01% |
+3,900
| New | +$245K |
|
989
PUT
Agilent Technologies
A
$41.2B
| $245K | ﹤0.01% |
+4,100
| New | +$234K |
|
990
Hackett Group
HCKT
$287M
| $245K | ﹤0.01% |
15,837
-18,287
| -54% | -$310K |
|
991
Vertex Pharmaceuticals
VRTX
$126B
| $245K | ﹤0.01% |
1,900
-26,037
| -93% | -$3.13M |
|
|
SLCA
992
CALL
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $245K | ﹤0.01% |
+6,800
| New | +$268K |
|
|
PGEM
993
DELISTED
Ply Gem Holdings, Inc.
PGEM
| $245K | ﹤0.01% |
13,634
-24,621
| -64% | -$442K |
|
|
VMW
994
CALL
DELISTED
VMware, Inc
VMW
| $243K | ﹤0.01% |
+2,800
| New | +$258K |
|
995
PUT
Duluth Holdings
DLTH
$159M
| $242K | ﹤0.01% |
13,300
-4,300
| -24% | -$85.2K |
|
|
ASB.WS
996
DELISTED
Associated Banc-Corp Warrants
ASB.WS
| $242K | ﹤0.01% |
41,341
+1,341
| +3% | +$7.24K |
|
997
Lesaka Technologies
LSAK
$420M
| $241K | ﹤0.01% |
24,471
+11,208
| +85% | +$114K |
|
998
PUT
Nabors Industries
NBR
$1.21B
| $241K | ﹤0.01% |
+592
| New | +$298K |
|
999
CALL
Under Armour
UAA
$2.6B
| $240K | ﹤0.01% |
11,000
-10,700
| -49% | -$218K |
|
|
CONN
1000
CALL
DELISTED
Conn's Inc.
CONN
| $240K | ﹤0.01% |
12,500
-26,800
| -68% | -$434K |
|
Similar funds
CAM
MRCP
ECP
TCG
PC
CCI
DIG
CLG
Highbridge Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Highbridge Capital Management held 1,898 positions worth $6.7B, down 2.7% from $6.89B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Highbridge Capital Management withdrew a net $1.21B in Q2 2017, closing 709 positions and reducing 343 holdings. Its most notable exit was Syngenta Ag, an estimated $35.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, up from 7.4% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Highbridge Capital Management opened a new position in Altaba Inc worth $52.6M.
- Highbridge Capital Management's largest Q2 2017 buy was Altaba Inc: 964,955 shares worth $52.6M.
- Highbridge Capital Management added most to Alibaba in Q2 2017, an estimated $91.8M increase.
- Highbridge Capital Management's biggest Q2 2017 reduction was Hewlett Packard, cutting an estimated $33.6M.
- Highbridge Capital Management fully exited Syngenta Ag in Q2 2017, selling an estimated $35.4M.
- Highbridge Capital Management's ten largest holdings make up 20% of its $6.7B portfolio in Q2 2017.
- Highbridge Capital Management opened 496 new positions and closed 709 in Q2 2017.
- Highbridge Capital Management's portfolio value fell 2.7% quarter-over-quarter to $6.7B.
Based on Highbridge Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.